Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Current Assets: 2019-2025

Historic Current Assets for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to $838.8 million.

  • Harmony Biosciences Holdings' Current Assets rose 60.57% to $838.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $838.8 million, marking a year-over-year increase of 60.57%. This contributed to the annual value of $579.3 million for FY2024, which is 28.42% up from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Current Assets is $838.8 million, which was up 21.33% from $691.4 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Current Assets ranged from a high of $838.8 million in Q3 2025 and a low of $177.7 million during Q1 2021.
  • In the last 3 years, Harmony Biosciences Holdings' Current Assets had a median value of $479.5 million in 2024 and averaged $545.5 million.
  • Per our database at Business Quant, Harmony Biosciences Holdings' Current Assets fell by 3.82% in 2021 and then skyrocketed by 60.57% in 2025.
  • Quarterly analysis of 5 years shows Harmony Biosciences Holdings' Current Assets stood at $284.4 million in 2021, then soared by 40.73% to $400.3 million in 2022, then rose by 12.69% to $451.1 million in 2023, then grew by 28.42% to $579.3 million in 2024, then surged by 60.57% to $838.8 million in 2025.
  • Its Current Assets was $838.8 million in Q3 2025, compared to $691.4 million in Q2 2025 and $642.7 million in Q1 2025.